Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.08%17.712.0%$175.25m
SAGESAGE Therapeutics, Inc.
-4.77%130.749.5%$118.01m
PRGOPerrigo Co. Plc
-0.11%44.936.8%$94.10m
JAZZJazz Pharmaceuticals Plc
-0.51%128.012.2%$86.97m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.52%135.756.3%$79.38m
PTLAPortola Pharmaceuticals, Inc.
-0.98%25.287.7%$54.81m
ICPTIntercept Pharmaceuticals, Inc.
-0.27%110.6318.6%$52.78m
AXSMAxsome Therapeutics, Inc.
-2.35%8.322.7%$45.53m
MNKMallinckrodt Plc
0.95%20.1821.1%$40.16m
ICLRICON Plc
0.26%132.624.1%$39.69m
CTLTCatalent Inc
-0.17%35.332.4%$39.21m
UTHRUnited Therapeutics Corporation
0.63%114.6214.4%$36.86m
ENDPEndo International Plc
1.83%9.468.9%$33.35m
HZNPHorizon Pharma plc
-0.18%21.887.4%$27.15m
PCRXPacira Pharmaceuticals, Inc.
-1.61%39.8110.6%$26.46m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO.